This is the authors' abstract. We don't add key points for this paper.
Low-level laser therapy (LLLT), also referred to as photobiomodulation, involves the application of red or near-infrared (NIR) light to modulate cellular processes [1, 2]. NIR light therapy is widely used in the treatment of musculoskeletal disorders [3] and is increasingly promoted as a potential intervention for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) [4, 5]. The proposed mechanisms involve the stimulation of cytochrome c oxidase (COX) activity in mitochondria, which is thought to enhance ATP and reactive oxygen species (ROS) production, leading to the expression of antioxidant and anti-apoptotic genes [1, 2].
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tittelmeier et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: